Abexxa Biologics

Manufacturing · Texas, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Nanofab Bldg 500 S Cooper St Ste 203, Ar...

Phone Number

(817) 901-9610

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Abexxa Biologics

Abexxa Biologics is a biopharmaceutical company taking a new approach in the fields of immuno-oncology and oncology to develop the next generation of precision medicine. Abexxa is focused on developing novel therapeutics around its newly discovered class of intracellular antigens (atypical HLA-peptide complexes) on cancerous cells. These atypical HLA-peptide complexes provide access to previously un-druggable targets and have been shown to play a regulatory role in modulating innate and adaptive immune responses. Abexxa has developed a target discovery and validation platform, and a robust method to create highly specific human antibodies to those targets. These are being developed for various therapeutic drug formats, including direct tumor killing as well as mediating tumor death through immune modulation.Explore more
Abexxa Biologics's Social MediaPopular SearchesAbeXXa Biologics IncAbexxa BiologicsAbexxaSIC Code 28,283NAICS Code 32,325Show more

Abexxa Biologics Org Chart

PhoneEmail
KF
United States flag for contact location.

Senior Scientist

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Abexxa Biologics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Abexxa Biologics

Compare insights from companies similar to Abexxa Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Abexxa Biologics

<$5M
11-50
Private
<$5M
2015
KF
Kazi FattahSenior Scientist
$7.2M
11-50
Private
<$5M
2014
<$5M
11-50
Private
-
-
<$5M
11-50
Private
-
2019
SL
Shu-Hui LiuChief Scientific Officer
<$5M
1-10
Private
-
2017
AG
Abner Garcia-DelgadoGlobal Vice President, Operations
<$5M
11-50
Public
$213.8M
2014
CS
Cynthia SirardChief Medical Officer
<$5M
1-10
Private
-
2012
JC
Judy ChiaoSenior VP, Clinical Development
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Abexxa Biologics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Abexxa Biologics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Abexxa Biologics.

Abexxa Biologics financials insights

Gather financial insights about Abexxa Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2016

Private Equity

$1.2M

See All Abexxa Biologics's Financials Insights

Abexxa Biologics Tech Stack

A closer look at the technologies used by Abexxa Biologics

See more technologies

Abexxa Biologics News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Abexxa Biologics

What is Abexxa Biologics's official website?
Abexxa Biologics's official website is www.abexxa.com
What is Abexxa Biologics's Revenue?
Abexxa Biologics's revenue is <$5 Million
What is Abexxa Biologics's SIC code?
Abexxa Biologics's SIC: 28,283
What is Abexxa Biologics's NAICS code?
Abexxa Biologics's NAICS: 32,325
How many employees does Abexxa Biologics have?
Abexxa Biologics has 11-50 employees
What industry does Abexxa Biologics belong to?
Abexxa Biologics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Abexxa Biologics competition?
Abexxa Biologics top competitors include: L&L Biopharma, Vigeo Therapeutics, SystImmune, CytoImmune Therapeutics
What companies has Abexxa Biologics acquired?
Abexxa Biologics has acquired the companies: Ancare Australia, Boehringer Ingelheim, HeartlandVetSupply.com, Torch Insight
What technology does Abexxa Biologics use?
Some of the popular technologies that Abexxa Biologics uses are: HostPapa
How do I contact Abexxa Biologics?
Abexxa Biologics contact info: Phone number: (817) 901-9610 Website: www.abexxa.com
What does Abexxa Biologics do?

Abexxa Biologics is a biopharmaceutical company taking a new approach in the fields of immuno-oncology and oncology to develop the next generation of precision medicine. Abexxa is focused on developing novel therapeutics around its newly discovered class of intracellular antigens (atypical HLA-peptide complexes) on cancerous cells. These atypical H... LA-peptide complexes provide access to previously un-druggable targets and have been shown to play a regulatory role in modulating innate and adaptive immune responses. Abexxa has developed a target discovery and validation platform, and a robust method to create highly specific human antibodies to those targets. These are being developed for various therapeutic drug formats, including direct tumor killing as well as mediating tumor death through immune modulation.Read More

What are Abexxa Biologics social media links?
Abexxa Biologics Linkedin page Abexxa Biologics Twitter page
Is Abexxa Biologics a public company?
Abexxa Biologics is private company therefore does not currently have an official ticker symbol
See more information about Abexxa Biologics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.